Literature DB >> 9222552

Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity.

F Orosz1, J Kovács, P Löw, B G Vértessy, Z Urbányi, T Acs, T Keve, J Ovádi.   

Abstract

1. KAR-2 (3"-(beta-chloroethyl)-2",4"-dioxo-3,5"-spiro-oxazolidino- 4-deacetoxy-vinblastine), is a bis-indol derivative; catharantine is coupled with the vindoline moiety which contains a substituted oxazolidino group. Our binding studies showed that KAR-2 exhibited high affinity for bovine purified brain tubulin (Kd-3 microM) and it inhibited microtubule assembly at a concentration of 10 nM. 2. Anti-microtubular activity of KAR-2 was highly dependent on the ultrastructure of microtubules: while the single tubules were sensitive, the tubules cross-linked by phosphofructokinase (ATP: D-fructose-6-phosphate-1-phosphotransferase, EC 2.7.1.11) exhibited significant resistance against KAR-2. 3. The cytoplasmic microtubules of Chinese hamster ovary mammalian and Sf9 insect cells were damaged by 1 microgram ml-1 KAR-2, as observed by indirect immunofluorescence and transmission electron microscopy. Scanning electron microscopy revealed intensive surface blebbing on both types of cells in the presence of KAR-2. 4. KAR-2 was effective in the mouse leukaemia P338 test in vivo without significant toxicity. Studies on a primary cerebro-cortical culture of rat brain and differentiated PC12 cells indicated that the toxicity of KAR-2 was significantly lower than that of vinblastine. The additional property of KAR-2 that distinguishes it from bis-indol derivatives is the lack of anti-calmodulin activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222552      PMCID: PMC1564756          DOI: 10.1038/sj.bjp.0701189

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.

Authors:  Wagner Santos Coelho; Mauro Sola-Penna
Journal:  Mol Cell Biochem       Date:  2012-09-26       Impact factor: 3.396

2.  New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.

Authors:  F Orosz; B Comin; B Raïs; J Puigjaner; J Kovács; G Tárkányi; T Acs; T Keve; M Cascante; J Ovádi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

3.  Comparison of polymerization and structural behavior of microtubules in rat brain and sperm affected by the extremely low-frequency electromagnetic field.

Authors:  Dariush Gholami; Gholamhossein Riazi; Rouhollah Fathi; Mohsen Sharafi; Abdolhossein Shahverdi
Journal:  BMC Mol Cell Biol       Date:  2019-08-29

4.  Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy.

Authors:  A Lehotzky; N Tokési; I Gonzalez-Alvarez; V Merino; M Bermejo; F Orosz; P Lau; G G Kovacs; J Ovádi
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2008-10-13       Impact factor: 4.226

5.  Evidence-Based Structural Model of the Staphylococcal Repressor Protein: Separation of Functions into Different Domains.

Authors:  Kinga Nyíri; Bianka Kőhegyi; András Micsonai; József Kardos; Beata G Vertessy
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.